Robert D. Pesek
Professor
faculty
Peds Pediatrics, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Robert D. Pesek's research focuses on allergic and immunologic conditions, particularly in children. He is an Assistant Professor of Allergy and Immunology at the University of Arkansas for Medical Sciences (UAMS) and serves as the medical director for the Allergy and Eosinophilic Gastrointestinal Disorders Clinics at Arkansas Children's Hospital (ACH). His clinical and research work addresses primary immunodeficiency, food allergies, and eosinophilic gastrointestinal disorders.
Dr. Pesek has contributed to the development of consensus recommendations and clinical severity indices for eosinophilic gastrointestinal diseases. His publications include studies on the use of dupilumab for eosinophilic esophagitis in young patients, tolerance development in infants with cow's milk allergy undergoing oral immunotherapy, and the development of core outcome sets and practical guides for managing eosinophilic esophagitis through diet therapy. He also investigates distinct trajectories of antigen-specific T cells in individuals undergoing oral immunotherapy for peanut allergy.
His scholarly output includes 69 publications, with an h-index of 19 and over 1,300 citations. Dr. Pesek collaborates with several faculty members at UAMS, including Akilah A. Jefferson, Erhan Ararat, Amy M. Scurlock, and Stacie M. Jones, and leads a research group.
Research Overview
Robbie Pesek, MD, is an Assistant Professor of Allergy and Immunology for the University of Arkansas forMedical Sciences (UAMS) and Arkansas Children's Hospital. He is also the medical director for the Allergy and Eosinophilic Gastrointestinal Disorders Clinics at ACH. Dr. Pesek received his Bachelor of Science from the University of Arkansas at Fayetteville and completed his medical degree at UAMS. He completed his Pediatric residency at ACH and training in Allergy/Immunology at the University of South Florida in Tampa, Florida. He joined the faculty at ACH in 2011. Dr. Pesek is a member of the Arkansas Medical Society, American Academy of Pediatrics, American College of Allergy, Asthma, and Immunology, and the American Academy of Allergy, Asthma, and Immunology. His current research interests include primary immunodeficiency, food allergies, and eosinophilic gastrointestinal disorders. Some of the UAMS College of Medicine faculty members provide pediatric patient care at Arkansas Children's Hospital. In addition, a wide range of pediatric services are provided in more than 35 subspecialties around Arkansas in locations such as the Schmieding Developmental Center in Springdale and the James L. Dennis Developmental Center in Little Rock. To make an appointment at Arkansas Children's Hospital, please call 501-364-4000.
Metrics
- h-index: 20
- Publications: 69
- Citations: 1,355
Selected Publications
-
Patient-Reported Outcome Scores Are Comparable in Multiregional Versus Uniregional Eosinophilic Esophagitis (2025)
-
Current Practices Among 13 Severe Pediatric Asthma Programs in the United States (2025)
-
Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis (2025)
-
Video directly observed therapy to improve inhaler technique among pediatric patients with persistent asthma (2025)
-
Rare inborn error of immunity presenting as acute respiratory failure (2024)
-
S661 Dupilumab Improves Multiple Histopathologic Endpoints in Children With Eosinophilic Esophagitis: 52-Week Results From the Phase 3 EoE KIDS Trial (2024)
-
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections (2024)
-
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting (2024)
-
Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis (2024)
-
A Rare Condition Masquerading as a Common Disease (2024)
-
Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial (2024)
-
Food insecurity and allergic diseases: A call to collective action (2023)
-
Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting (2023)
-
Implementation of a Respiratory Therapist–Driven Protocol for Spirometry and Asthma Education in a Pediatric Out-Patient Primary Care Setting (2023)
-
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy (2023)
Grants & Funding
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- Eosinopilic Research Training UAMS ACHRI Flow Through Principal Investigator
- Eosinopilic Research Training UAMS ACHRI Flow Through Principal Investigator
- Eosinopilic Research Training UAMS ACHRI Flow Through Principal Investigator
- Eosinopilic Research Training UAMS ACHRI Flow Through Principal Investigator
Collaboration Network
Top Collaborators
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Showing 5 of 17 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
Showing 5 of 16 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Showing 5 of 15 shared publications
- Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial
- Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
Showing 5 of 15 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
Showing 5 of 10 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
Showing 5 of 10 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting
- Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial
- Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
Showing 5 of 10 shared publications
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
- Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting
- Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
Showing 5 of 9 shared publications
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Tolerance development in cow’s milk–allergic infants receiving amino acid–based formula: A randomized controlled trial
- Assessment of infant outgrowth of cow’s milk allergy in relation to the faecal microbiome and metaproteome
- Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting
- Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
Showing 5 of 9 shared publications
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
- Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
- A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus
Showing 5 of 8 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Showing 5 of 8 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
- A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus
Showing 5 of 8 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
- Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus
Showing 5 of 7 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
Showing 5 of 7 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
Showing 5 of 7 shared publications
Similar Researchers
Based on overlapping research topics